Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 14, 2020 03:00 ET | Source: Light Chain Bioscience - NovImmune SA

Light Chain Bioscience successfully completes Factor VIII mimetic bispecific antibody discovery for Takeda

GENEVA, Switzerland, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Light Chain Bioscience, a company developing bispecific antibodies with a pipeline focused in immuno-oncology, announced that it has achieved a...